Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
KEYWORDS: people, treatment, anticoagulation, dvt, committee, anticoagulation treatment, evidence, vte, recommendations, risk, cancer, agreed, clinical, use, d-dimer

the rationale and impact section on outpatient treatment for low-risk PE. Full details of the evidence and the committee's discussion are in evidence review E: outpatient treatment of low-risk pulmonary embolism. 1.3 Anticoagulation treatment for suspected or confirmed DVT or PE NICE has produced a visual summary of the recommendations on anticoagulation treatment for DVT or PE. 1.3.1 When offering anticoagulation treatment, follow the recommendations on shared decision making and supporting adherence in the NICE guidelines on medicines optimisation, medicines adherence, patient experience in adult NHS services and shared decision making. [2020] Interim therapeutic anticoagulation for suspected DVT or PE 1.3.2 Follow the recommendations on when to offer interim therapeutic anticoagulation for suspected proximal DVT or PE in the section on diagnosis and initial management. [2020] 1.3.3 If possible, choose an interim anticoagulant that can be continued if DVT or PE is confirmed (see the section on anticoagulation treatment for confirmed DVT or PE). [2020] In March 2020, direct-acting anticoagulants and some low molecular weight heparins (LMWHs) were off label for the treatment of suspected DVT or PE. See NICE's information on prescribing medicines. 1.3.4 When using interim therapeutic anticoagulation for suspected proximal DVT or PE: â€¢ carry out baseline
